SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology

NCT06053086 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

RADIATION: Treatment ETHOS radiotherapy
RADIATION: Conventional IMRT

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle